Advertisement
Screener

CARDIFF ONCOLOGY, INC. (CRDF) Form D

CARDIFF ONCOLOGY, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-06-23: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-06-16; Total offering amount $13,500,000.
  • 2020-06-01: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-05-26; Total offering amount $2,500,000.
  • 2020-04-14: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2020-03-30; Total offering amount $2,084,000.
  • 2019-10-30: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2019-10-30; Total offering amount $5,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-06-23Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2020-06-16$13,500,000$13,500,000$03
2020-06-01Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2020-05-26$2,500,000$2,500,000$01
2020-04-14Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2020-03-30$2,084,000$2,084,000$01
2019-10-30Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2019-10-30$5,000,000$5,000,000$02
2019-08-28Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2019-08-22$1,500,000$1,500,000$01
2019-05-20Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2019-05-15$1,500,000$1,500,000$01
2019-04-10Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2019-04-05$1,500,000$1,500,000$01
2017-07-24Rule 506(b)OptionToAcquire; SecurityToBeAcquired2017-07-19$6,547,512$0$6,547,5124
2012-12-07Rule 506Equity; OptionToAcquire2012-11-21$4,420,000$3,760,000$660,0008
2012-03-26Rule 506Equity; OptionToAcquire2009-06-10$6,598,200$6,598,200$040

Similar stocks

Stock NameCountryMarket CapPE Ratio
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Vaxart, Inc. (VXRT)United States$0.080B3.84
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B